Jie Mei

1.1k citations
48 papers · 890 indexed · h-index 18
    • Cancer-related molecular mechanisms research 4
    • MicroRNA in disease regulation 3
    • Advanced biosensing and bioanalysis techniques 6
    • Extracellular vesicles in disease 4
    • RNA modifications and cancer 4
    • Nanoplatforms for cancer theranostics 6
    • Microfluidic and Capillary Electrophoresis Applications 5
    • Immune cells in cancer 7

Jie Mei

44 papers receiving 882 citations

Peers

Jie Mei
Comparison fields: 5 of 112
  • Cancer Research 203
  • Molecular Biology 436
  • Biomedical Engineering 254
  • Biomaterials 74
  • Immunology 112
Replace Huiping Lu with:
Huiping Lu China
Abbas Salihi Iraq
Rongrong Zhang China
Qun Chen China
Yanru Qin China
Hongyang Li China
Ning Xiao China
Juntao Xu China
Patrizia Cancemi Italy
Ronghua Shi China
Jie Mei relative to Huiping Lu China Huiping Lu's profile →
Citations per field
00.5×1.5×2.2×
Huiping Lu · 1×
Citations per year

Countries citing papers authored by Jie Mei

Since Specialization
Citations

This map shows the geographic impact of Jie Mei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jie Mei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jie Mei more than expected).

Fields of papers citing papers by Jie Mei

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jie Mei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jie Mei. The network helps show where Jie Mei may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Jie Mei, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Jie Mei Line = papers co-authored together Jie Mei links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20250
2 20253
3 20250
4 20252
5 20252
6 20241
7 20232
8 202326
9 202314
10 20228
11 202123
12 202153
13 202155
14 202032
15 202022
16 201822
17 201431
18 201310
19 201018
20 200824

About Jie Mei

Jie Mei is a scholar working on Immunology, Cancer Research and Molecular Medicine, having authored 48 papers that have together received 890 indexed citations. Recurring topics across this work include Immune cells in cancer (7 papers), Nanoplatforms for cancer theranostics (6 papers), Advanced biosensing and bioanalysis techniques (6 papers), Microfluidic and Capillary Electrophoresis Applications (5 papers), Cancer-related molecular mechanisms research (4 papers), Extracellular vesicles in disease (4 papers), RNA modifications and cancer (4 papers) and MicroRNA in disease regulation (3 papers). The work is most often cited by research in Cancer Research (203 citations), Molecular Biology (436 citations) and Biomedical Engineering (254 citations). Jie Mei has collaborated with scholars based in China, Canada and United States. Frequent co-authors include Chun‐Li Zhang, Robert Bachoo, Ying Liu, Yongfu Ma, Jipeng Jiang, Changjiang Feng, Shanshan Xu, Yuxiu Xiao, Shilin Li and Yueguang Xue. Their work appears in journals such as SHILAP Revista de lepidopterología, The EMBO Journal and ACS Nano.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026